MedTrace Logo

Supplementation of Land-based Stearidonic Acid (SDA)-Rich Oils in Humans

NCT01856179 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2013-05-17

No results posted yet for this study

Summary

The objective of this study is to investigate the conversion of the precursors ALA and SDA into n-3 LC-PUFA (EPA, DPA and DHA) in humans by oral supplementation of Echium oil in comparison with SDA soybean oil (positive control). In addition, the accumulation of n-3 LC-PUFA is compared between subpopulations of different age, gender and physiological conditions (overweight, increased serum total cholesterol).

Conditions

Interventions

DIETARY_SUPPLEMENT

Echium oil

Oil of Echium platagineum (natural plant oil) ca. 15-18 g/d (Croda)

Sponsors & Collaborators

  • German Research Foundation

    collaborator OTHER

  • University of Jena

    lead OTHER

Principal Investigators

  • Katrin Kuhnt, Dr. rer. nat · University of Jena, Insitute of Nutrition

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2011-08-31
Completion
2012-04-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01856179 on ClinicalTrials.gov